Profil
Torsten Hoffmann is a member of the American Chemical Society and the Swiss Chemical Society.
He was the Managing Director & Chief Scientific Officer at Proteros biostructures GmbH.
He was also the Head-Global Roche Postdoc at Roche Holding AG from 1999 to 2015.
In 2017 to 2018, he was the Chief Operating Officer at Silence Therapeutics Plc.
He was an Associate at The Scripps Research Institute and the Chief Scientific Officer at Oryzon Genomics SA. He was also the Chief Scientific Officer & Executive VP at Zealand Pharma A from 2013 to 2015.
Dr. Hoffmann holds a doctorate degree from the Swiss Federal Institute of Technology.
Currently, he holds positions as a member of the American Chemical Society and the Swiss Chemical Society.
Aktive Positionen von Torsten Hoffmann
| Unternehmen | Position | Beginn |
|---|---|---|
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Corporate Officer/Principal | - |
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Torsten Hoffmann
| Unternehmen | Position | Ende |
|---|---|---|
| SILENCE THERAPEUTICS PLC | Geschäftsführer | 21.06.2018 |
| ZEALAND PHARMA A/S | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2015 |
| ROCHE HOLDING AG | Corporate Officer/Principal | 01.01.2015 |
| ORYZON GENOMICS S.A. | Technik-/Wissenschafts-/F&E-Leiter | - |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Ausbildung von Torsten Hoffmann
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Roche Holding AG
Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Silence Therapeutics Plc
Silence Therapeutics Plc Miscellaneous Commercial ServicesCommercial Services Engages in the research and development of novel pharmaceutical products | Commercial Services |
The Scripps Research Institute
The Scripps Research Institute Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American Chemical Society
American Chemical Society Miscellaneous Commercial ServicesCommercial Services Operates as scientific society that supports scientific inquiry in the field of chemistry | Commercial Services |
Oryzon Genomics SA
Oryzon Genomics SA BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops epigenetics-based therapeutics | Health Technology |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Swiss Federal Institute of Technology
Swiss Federal Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Swiss Chemical Society
Swiss Chemical Society Miscellaneous Commercial ServicesCommercial Services Provides accounting services | Commercial Services |
Proteros biostructures GmbH
Proteros biostructures GmbH Medical/Nursing ServicesHealth Services Serves as a discovery service business | Health Services |
















